Covid-19 linked to schizophrenia.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): Wade, Grace (AUTHOR)
  • Source:
    New Scientist. 1/13/2024, Vol. 261 Issue 3473, p16-16. 1/2p.
  • Additional Information
    • Subject Terms:
      COVID-19; SCHIZOPHRENIA
    • Abstract:
      Severe infections with the SARS-CoV-2 virus, which causes Covid-19, appear to increase the risk of being diagnosed with schizophrenia or other psychotic disorders. This suggests that Covid-19 may heighten the risk of developing schizophrenia. Researchers analyzed data from over 650,000 people in the US National COVID Cohort Collaborative and found that those who had Covid-19 were 4.6 times more likely to be diagnosed with a psychotic condition compared to those who tested negative for the virus. The increased risk may be due to Covid-19 causing inflammation in the brain and elevated levels of a substance called kynurenic acid, which is associated with psychosis. [Extracted from the article]
    • Abstract:
      Copyright of New Scientist is the property of New Scientist Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)